Coloplast AS (XTER:CBHD) Cyclically Adjusted Book per Share: €6.07 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:CBHD Coloplast AS XTER:CBHD
71 GF Score
Price €56.20
GF Value €107.93
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Coloplast AS Cyclically Adjusted Book per Share?

Coloplast AS XTER:CBHD +0.04% 71 Cyclically Adjusted Book per Share is €6.07 as of Jun. 2026. GuruFocus rates XTER:CBHD with a GF Score™ of 71/100 and a GF Value™ of €107.93 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Coloplast AS's adjusted book value per share for the three months ended in Jun. 2026 was €7.935. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.07 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Coloplast AS's average Cyclically Adjusted Book Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Coloplast AS was 9.70% per year. The lowest was 4.90% per year. And the median was 7.45% per year.

As of today (2026-09-17), Coloplast AS's current stock price is €56.20. Coloplast AS's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €6.07. Coloplast AS's Cyclically Adjusted PB Ratio of today is 9.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Coloplast AS was 43.12. The lowest was 8.64. And the median was 25.91.


Coloplast AS  (XTER:CBHD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Coloplast AS's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=56.20/6.068
=9.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Coloplast AS was 43.12. The lowest was 8.64. And the median was 25.91.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Coloplast AS Cyclically Adjusted Book per Share Related Terms


Coloplast AS Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Cyclically Adjusted Book per Share Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.21 4.70 5.26 5.92 6.65

Coloplast AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.48 5.67 5.78 5.90 6.07

XTER:CBHD vs ISRG, BDX, RMD: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted PB Ratio falls into.


XTER:CBHD
71GF Score
Coloplast AS XTER:CBHD
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=7.935/122.9500*122.9500
=7.935

Current CPI (Jun. 2026) = 122.9500.

Coloplast AS Quarterly Data

Book Value per Share CPI Adj_Book
201609 3.214 100.200 3.944
201612 2.671 100.300 3.274
201703 3.210 101.200 3.900
201706 3.140 101.200 3.815
201709 3.769 101.800 4.552
201712 2.979 101.300 3.616
201803 3.401 101.700 4.112
201806 3.293 102.300 3.958
201809 4.053 102.400 4.866
201812 3.275 102.100 3.944
201903 3.892 102.900 4.650
201906 3.752 102.900 4.483
201909 4.359 102.900 5.208
201912 3.434 102.900 4.103
202003 4.147 103.300 4.936
202006 4.013 103.200 4.781
202009 4.678 103.500 5.557
202012 3.644 103.400 4.333
202103 4.380 104.300 5.163
202106 4.378 105.000 5.126
202109 5.162 105.800 5.999
202112 4.056 106.600 4.678
202203 4.603 109.900 5.150
202206 4.608 113.600 4.987
202209 5.253 116.400 5.549
202212 3.738 115.900 3.965
202303 4.445 117.300 4.659
202306 4.103 116.400 4.334
202309 10.326 117.400 10.814
202312 9.031 116.700 9.515
202403 9.651 118.400 10.022
202406 9.846 118.500 10.216
202409 10.681 118.900 11.045
202412 9.200 118.900 9.513
202503 10.076 120.200 10.307
202506 9.782 120.700 9.964
202509 9.584 121.600 9.690
202512 8.201 121.180 8.321
202603 7.626 121.670 7.706
202606 7.935 122.950 7.935

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €6.07 mean?
Coloplast AS (XTER:CBHD) has a Cyclically Adjusted Book per Share of €6.07 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Coloplast AS and its competitors.
Is Coloplast AS's Cyclically Adjusted Book per Share too high?
Coloplast AS's current Cyclically Adjusted Book per Share is €6.07. Overall, Coloplast AS has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Cyclically Adjusted Book per Share compare to ISRG and BDX?
Coloplast AS's Cyclically Adjusted Book per Share of €6.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Coloplast AS and its competitors. Coloplast AS's current Cyclically Adjusted Book per Share is €6.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (XTER:CBHD) is currently considered Significantly Undervalued. The stock's GF Value™ is €107.93, compared to a current price of €56.20 — trading 47.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is €6.07. Coloplast AS's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Coloplast AS (XTER:CBHD), the current Cyclically Adjusted Book per Share is €6.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (XTER:CBHD) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of €56.20 is trading 47.9% below its estimated GF Value™ of €107.93. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for XTER:CBHD:

  • Cyclically Adjusted Book per Share: €6.07
  • GF Value™: €107.93 vs. price of €56.20 (47.9% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the XTER:CBHD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
71GF Score

Get the complete analysis for XTER:CBHD

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.20
Price
€107.93
GF Value